Pharmaceutical and Medical Law: Legal Analytics and Insights

 

BRACE attorneys continuously monitor regulatory changes in the pharmaceutical and healthcare sectors. This section provides current legal analytics on the circulation of medicinal products, Dietary Supplements, and medical devices, alongside analyses of key court cases and regulatory trends in the life sciences industry.

 

Strategic breakdown of the legislative hierarchy and compliance checkpoints governing the state supply of medicinal products within the Russian Federation.

Public Procurement of Medicinal Products: Legal Regulation in Russia

Strategic legal framework for identifying and mitigating reputational risks and defamation within the Russian pharmaceutical and healthcare regulatory landscape.

Protection of the Business Reputation of Pharmaceutical and Medical Organizations in Russia

Strategic correlation between patent validity periods and eligibility criteria for international manufacturers within the state procurement system.

Violation and Protection of Intellectual Property Rights in Public Procurement of Medicinal Products

Strategic map illustrating the hierarchy of judicial appeals and common regulatory triggers for reimbursement denials within international healthcare compliance frameworks.

Denial of Payment for Medical Care Provided under CHI

Strategic breakdown of the mandatory labeling elements and serialization requirements for medicinal products entering the Russian market under national and EAEU frameworks.

Packaging of Medicinal Products in Russia

Strategic overview of the regulatory lifecycle for medicinal products, highlighting the intersection of clinical evidence and administrative compliance required for successful VED list inclusion.

Inclusion in and Exclusion from the VED List and Other Lists of Medicinal Products

Strategic mapping of legal boundaries and compliance requirements for medical representative interactions within the highly regulated life sciences sector.

Medical Representatives in the Pharmaceutical and Medical Device Markets

This analytical flowchart delineates the multi-stage regulatory approval process for drug development in the Russian Federation, highlighting critical compliance checkpoints and intellectual property safeguards for international pharmaceutical sponsors.

Research & Development of Medicinal Products: Requirements of Russian Legislation

Strategic overview of the MDLP regulatory framework, highlighting critical compliance checkpoints for international pharmaceutical manufacturers and distributors.

The MDLP System (Monitoring of Medicinal Product Movement for Medical Use)

A strategic overview of the antimonopoly regulatory framework governing the life sciences sector, illustrating the intersection of competition law and market access for international entities.

Antitrust Restrictions in Russian Pharma & Medical Device Markets

E-mail
info@brace-lf.com

Send us a request with a detailed description of the issue.

Our phone
+7 (495) 147-11-03

Contact us by phone.

Clients & Partners

65.png
68.png
69.png
73.png
75.png
fitera.jpg
imko.png
logo.png
Logo_RED_RGB_Rus.png
logo_SK_2.png